Parkman Healthcare Partners’s UroGen Pharma URGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.42M | Sell |
176,702
-216,451
| -55% | -$2.97M | 0.28% | 77 |
|
|
2025
Q1 | $4.35M | Buy |
393,153
+23,292
| +6% | +$258K | 0.52% | 56 |
|
|
2024
Q4 | $3.94M | Buy |
369,861
+22,320
| +6% | +$238K | 0.52% | 52 |
|
|
2024
Q3 | $4.41M | Buy |
347,541
+73,076
| +27% | +$928K | 0.56% | 57 |
|
|
2024
Q2 | $4.61M | Buy |
274,465
+90,281
| +49% | +$1.51M | 0.62% | 56 |
|
|
2024
Q1 | $2.76M | Buy |
184,184
+8,684
| +5% | +$130K | 0.34% | 74 |
|
|
2023
Q4 | $2.63M | Buy |
175,500
+30,189
| +21% | +$453K | 0.37% | 67 |
|
|
2023
Q3 | $2.04M | Buy |
+145,311
| New | +$2.04M | 0.37% | 73 |
|